Sleep apnea is highly prevalent in patients with cardiovascular disease. These disordered
breathing events are associated with a profile of perturbations that include intermittent …

Both oxidative stress and inflammation are enhanced in chronic heart failure. Dysfunction of
cardiac mitochondria is a hallmark of heart failure and a leading cause of oxidative stress …

The regulatory landscape for device-based heart failure (HF) therapies has seen a major
shift in the last 7 years. In 2013, the US Food and Drug Administration released guidance for …

Objectives: This prospective study investigated the prevalence of sleep-disordered
breathing (SDB) and its predictors in patients with stable chronic heart failure (HF) …

Background Central sleep apnoea is a serious breathing disorder associated with poor
outcomes. The remedé system (Respicardia Inc, Minnetonka, MN, USA) is an implantable …

Awareness of the importance of sleep-related disorders in patients with cardiovascular
diseases is growing. In particular, sleep-disordered breathing, short sleep time, and low …

Central sleep apnea (CSA) is thought to occur in about 1–5% of healthy children. CSA
occurs more commonly in children with underlying disease and the presence of CSA may …

Aims The presence of central sleep apnoea (CSA) is associated with poor prognosis in
patients with heart failure (HF). The aim of this analysis was to evaluate if using phrenic …

Sleep disorders in older adults increase with aging, likely due to increased sleep latency,
decreased sleep efficiency, and total sleep time. Common sleep issues include chronic …

Background: Large trials using noninvasive mechanical ventilation to treat central apnea
(CA) occurring at night (“sleep apnea”) in patients with systolic heart failure (HF) have failed …